Skip to main content

Oncology

Leukemia, Oncology

Umbralisib plus Ublituximab Combination Superior to Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia

Wayne Kuznar

Leukemia, Oncology

First-Line Fixed-Duration Ibrutinib plus Venetoclax Therapy Leads to Deep Remissions in Patients with Chronic Lymphocytic Leukemia

Phoebe Starr

Leukemia, Oncology

Oral Azacitidine Extends Survival in Acute Myeloid Leukemia, Regardless of MRD Status, in Patients in Remission After Chemotherapy

Wayne Kuznar

FDA Approvals, Multiple Myeloma, Oncology

Xpovio Approved for Patients with Relapsed or Refractory Multiple Myeloma

FDA Approvals, Lung Cancer, Oncology

Tagrisso Approved as Adjuvant Therapy for NSCLC with EGFR Mutations

Multiple Myeloma, Oncology

Belantamab Induces Deep Responses in Heavily Pretreated Patients with Relapsed or Refractory Multiple Myeloma

Wayne Kuznar

Leukemia, Oncology

Asciminib, First-in-Class STAMP Inhibitor, Superior to Bosutinib in Chronic-Phase CML

Phoebe Starr

Multiple Myeloma, Oncology, Bispecific Antibodies

Bispecific Antibodies in Phase 1 Studies Show Promising Efficacy in Heavily Pretreated Patients with Multiple Myeloma

Wayne Kuznar

FDA Approvals, Leukemia, Oncology

Oral Onureg First Drug Approved for Adults with AML in Remission

Disparities in Cancer Care, Oncology

AACR’s Cancer Disparities Inaugural Report Addresses Care Inequities

Wayne Kuznar, Medical Writer

Wayne Kuznar

Page 4 of 27
Results 31 - 40 of 262